In an effort to reallocate resources to its growing oncology focus in the face of shrinking COVID-19 vaccine sales, German ...

Sanofi is supercharging its artificial intelligence capabilities. | Sanofi is supercharging its artificial intelligence ...

Novartis is continuing its multiyear overhaul with new plans to shutter its production facility in Wehr, Germany. | Novartis ...

The California-based biotech has hired Omeros and AbbVie alum Nadia Dac as its new chief commercial officer, where she will ...

Fresh off gaining an FDA expansion for Auvelity as a treatment for Alzheimer’s disease agitation (ADA), Axsome Therapeutics ...

Created from the merger of Mallinckrodt and Endo last year, Keenova is launching the first Dupuytren's contracture campaign ...

Robert Blum and Fady Malik, M.D., Ph.D, have been with Cytokinetics since its inception nearly three decades ago. | ...

Pfizer is also demonstrating that its commercial portfolio can flourish beyond the historically mammoth sales of its COVID-19 ...

Neurocrine Biosciences has shared survey data showing how tardive dyskinesia (TD) affects the ability of patients and ...

Though largely operating in the background until recently, Prolific Machines’ optogenetic approach to biomanufacturing is set ...

After topping up its long-running operations in Puerto Rico with plans for a $650 million investment last year, Amgen is ...

A union strike of thousands of workers is still ongoing at Korean CDMO Samsung Biologics, costing the company over a million ...